Vorinostat

Cysolvia® is one of brands under Miedykol® a high-end and certified active pharmaceutical ingredients (APIs) and pharmaceutical intermediates manufacturer in China, mainly providing various APIs products and customized production (CMO/CDMO). We produce the vorinostat (or suberoylanilide hydroxamic acid (SAHA)) product known as histone deacetylase inhibitors and was approved by the US FDA in 2006. It is a significant active ingredient in crafting skin cancer targeted drugs for the treatment of cutaneous T cell lymphoma (CTCL), used when the disease continues or relapses during or after treatment with other medicines. At Miedykol, we produce the well-developed and market much-needed active ingredients in making cancer targeted drugs. We also support your cancer and tumor clinical therapies with the tailored production and integrative preparation solutions. Reach out to us for further information. Vorinostat (rINN) or , is an active ingredient , a type of skin cancer. . It is the first in a new class of agents .